ArticleCancer cell international2023

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.

Hayden L Bell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.